Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Non-Small-Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07641023
What this trial is testing

Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic
Beijing Biotech 60
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Testing effectiveness (Phase 2)Study completedNCT00918203
What this trial is testing

Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 137
Testing effectiveness (Phase 2)Looking for participantsNCT07164170
What this trial is testing

Clinical Study of Combination Therapy With ABSK043 and Glecirasib

Who this might be right for
Non-Small Cell Lung Cancer
Abbisko Therapeutics Co, Ltd 86
Early research (Phase 1)Active Not RecruitingNCT04612751
What this trial is testing

Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic NSCLC
AstraZeneca 155
Early research (Phase 1)Looking for participantsNCT05948865
What this trial is testing

CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerCancer, Lung
Conjupro Biotherapeutics, Inc. 132
Large-scale testing (Phase 3)Not Yet RecruitingNCT07718737
What this trial is testing

Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Multitude Therapeutics Inc. 512
Early research (Phase 1)Study completedNCT02857270
What this trial is testing

LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more
Eli Lilly and Company 210
Testing effectiveness (Phase 2)Looking for participantsNCT05910827
What this trial is testing

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

Who this might be right for
Advanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+4 more
Hummingbird Bioscience 398
Post-approval studies (Phase 4)UnknownNCT04814056
What this trial is testing

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

Who this might be right for
NRG1-fused Non-small Cell Lung Cancer
Shanghai Chest Hospital 15
Testing effectiveness (Phase 2)UnknownNCT05552781
What this trial is testing

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
RedCloud Bio 76
Early research (Phase 1)Study completedNCT00496275
What this trial is testing

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 17
Testing effectiveness (Phase 2)Ended earlyNCT01057212
What this trial is testing

Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Providence Health & Services 6
Early research (Phase 1)Study completedNCT02014337
What this trial is testing

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Who this might be right for
Breast CancerOvarian Epithelial Cancer RecurrentSarcoma+4 more
Corcept Therapeutics 37
Early research (Phase 1)Looking for participantsNCT07056556
What this trial is testing

BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 31
Early research (Phase 1)Active Not RecruitingNCT05557045
What this trial is testing

JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

Who this might be right for
Advanced CancerMetastatic CancerSolid Tumor+4 more
Jazz Pharmaceuticals 98
Large-scale testing (Phase 3)Looking for participantsNCT06980272
What this trial is testing

SSGJ-707 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Shenyang Sunshine Pharmaceutical Co., LTD. 420
Large-scale testing (Phase 3)Study completedNCT00034879
What this trial is testing

Iressa Expanded Access Program (EAP)

Who this might be right for
CarcinomaNon-small-cell LungMetastases+1 more
AstraZeneca
Early research (Phase 1)Ended earlyNCT03255083
What this trial is testing

DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 13
Testing effectiveness (Phase 2)Ended earlyNCT05662670
What this trial is testing

A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic NSCLC
Suzhou Junjing BioSciences Co., Ltd. 14
Next Page